We investigated the role of obesity on morbidity and mortality in patients undergoing above knee amputation.
Methods
Data of 4225 patients undergoing AKAs was extracted from NIS Database (2016–2019) for a retrospectively matched case-control study and were grouped into; Non-obese (N-Ob-BMI <29.9 kg/m2; n = 1413), class I/II obese (Ob-I/II-BMI: 30–39.9 kg/m2; n = 1413), and class III obese groups (Ob-IIIBMI > 40; n = 1399). Morbidity, mortality, length of stay, and hospital charges were analyzed.
Results
Blood loss anemia (OR = 1.42; 95% CI = 1.19–1.64), superficial SSI (OR = 5.10; 95% CI = 1.4717.63) and acute kidney injury (AKI- OR = 1.42; 95% CI = 1.21–1.67) were higher in Ob-III patients. Mortality was 5.8%, 4.5%, and 6.4% in N-Ob, Ob-I/II and Ob-III patients (p < 0.001; Ob-I/II vs. Ob-III), respectively. Hospital LOS was 3 days higher in Ob-III (16.1 ± 18.0), comparatively resulting in $25,481 higher inpatient-hospital charge.
Conclusion
Patients in Ob-III group were noted to have increased morbidity, higher LOS, and inpatient-hospital cost.
TsaiSLanierHDTranN, et al.Current predictors of mortality in veteran patients undergoing major lower extremity amputations: risk factors have not changed and mortality remains high. Am Surg2022: 000313482210742. DOI: 10.1177/00031348221074235.
2.
FanaroffACYangLNathanAS, et al.Geographic and socioeconomic disparities in major lower extremity amputation rates in metropolitan areas. J Am Heart Assoc2021; 10(17): e021456. DOI: 10.1161/JAHA.121.021456.
3.
DvorakJELesterELWMalusoPJ, et al.The obesity paradox in the trauma patient: normal may not be better. World J Surg2020; 44(6): 1817–1823. DOI: 10.1007/s00268-020-05398-1.
4.
DavenportDLXenosESHosokawaP, et al.The influence of body mass index obesity status on vascular surgery 30-day morbidity and mortality. J Vasc Surg2009; 49(1): 140–147. DOI: 10.1016/j.jvs.2008.08.052.
5.
HuertaSTranNYiB, et al.Outcomes of obese compared to non-obese veterans undergoing open inguinal hernia repair: a case-control study. Hernia2021; 25(5): 1289–1294. DOI: 10.1007/s10029021-02382-z.
6.
ServánPR. Obesity and diabetes. Nutr Hosp2013; 28(Supl 5): 138–143.
7.
ChopraAAzarbalAFJungE, et al.Ambulation and functional outcome after major lower extremity amputation. J Vasc Surg2018; 67(5): 1521–1529. DOI: 10.1016/j.jvs.2017.10.051.
8.
KelleyKATsikitisVL. Clinical research using the national inpatient sample: a brief review of colorectal studies utilizing the NIS database. Clin Colon Rectal Surg2019; 32(1): 33–40. DOI: 10.1055/s-0038-1673352.
9.
NuttallFQ. Body mass index: obesity, BMI, and health: a critical review. Nutr Today2015; 50(3): 117–128. DOI: 10.1097/NT.0000000000000092.
10.
FrancischettiEAGenelhuVA. Obesity-hypertension: an ongoing pandemic. Int J Clin Pract2007; 61(2): 269–280. DOI: 10.1111/j.1742-1241.2006.01262.x.
11.
HubertHBFeinleibMMcNamaraPM, et al.Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation1983; 67(5): 968–977. DOI: 10.1161/01.cir.67.5.968.
12.
KenchaiahSEvansJCLevyD, et al.Obesity and the risk of heart failure. N Engl J Med2002; 347(5): 305–313. DOI: 10.1056/NEJMoa020245.
13.
AdamsKFSchatzkinAHarrisTB, et al.Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med2006; 355(8): 763–778. DOI: 10.1056/NEJMoa055643.
14.
BanackHRKaufmanJS. The obesity paradox: understanding the effect of obesity on mortality among individuals with cardiovascular disease. Prev Med2014; 62: 96–102. DOI: 10.1016/j.ypmed.2014.02.003.
15.
LavieCJOsmanAFMilaniRV, et al.Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol2003; 91(7): 891–894. DOI: 10.1016/s00029149(03)00031-6.
16.
CurtisJPSelterJGWangY, et al.The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med2005; 165(1): 55–61. DOI: 10.1001/archinte.165.1.55.
17.
GrubergLMercadoNMiloS, et al.Impact of body mass index on the outcome of patients with multivessel disease randomized to either coronary artery bypass grafting or stenting in the ARTS trial: The obesity paradox II?Am J Cardiol2005; 95(4): 439–444. DOI: 10.1016/j.amjcard.2004.10.007.
18.
DixonJBLambertGW. The obesity paradox--a reality that requires explanation and clinical interpretation. Atherosclerosis2013; 226(1): 47–48. DOI: 10.1016/j.atherosclerosis.2012.11.005.
19.
OreopoulosAPadwalRKalantar-ZadehK, et al.Body mass index and mortality in heart failure: a meta-analysis. Am Heart J2008; 156(1): 13–22. DOI: 10.1016/j.ahj.2008.02.014.
20.
NicholsonMLDennisMJMakinGS, et al.Obesity as a risk factor in major reconstructive vascular surgery. Eur J Vasc Surg1994; 8(2): 209–213. DOI: 10.1016/s0950821x(05)80462-1.
21.
JacksonBMEnglishSJFairmanRM, et al.Carotid artery stenting: identification of risk factors for poor outcomes. J Vasc Surg2008; 48(1): 74–79. DOI: 10.1016/j.jvs.2008.02.005.
22.
ChangJKCalligaroKDRyanS, et al.Risk factors associated with infection of lower extremity revascularization: analysis of 365 procedures performed at a teaching hospital. Ann Vasc Surg2003; 17(1): 91–96. DOI: 10.1007/s10016-001-0337-8.
23.
SohnMWBudiman-MakEOhEH, et al.Obesity paradox in amputation risk among nonelderly diabetic men. Obesity (Silver Spring)2012; 20(2): 460–462. DOI: 10.1038/oby.2011.301.
